Toxicity of cysteine and cysteine sulphinic acid to human neuronal cell- lines

Journal of the Neurological Sciences

Volumn 152, Issue SUPPL. 1, 1997, Pages

  Parsons, R B ^a   Waring, R H ^a   Ramsden, D B ^a   Williams, A C ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Cell lines; Cysteine; Cysteine dioxygenase; Cysteine sulfinic acid; Neurotoxicity; Sulfur amino acids

Indexed keywords

CYSTEINE; CYSTEINE DERIVATIVE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

CELL DEATH; CELL SURVIVAL; CONFERENCE PAPER; CYTOTOXICITY; DEGENERATIVE DISEASE; HUMAN; HUMAN CELL; NERVE CELL CULTURE; NEUROTOXICITY; PRIORITY JOURNAL;

CELL LINE; CELL SURVIVAL; CYSTEINE; HUMANS; NEURONS; NEUROTRANSMITTER AGENTS; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0030658782     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(97)00246-3     Document Type: Conference Paper

References (13)

1. Boss V., Nutt K.M., Cain P.J. L-Cysteine sulfinic acid as an endogenous agonist of a novel metabotropic receptor coupled to stimulation of phospholipase D activity. Mol. Pharmacol. 45(6):1994;1177-1182.
2. Choi D.W. Methods for antagonising glutamate neurotoxicity. Cerebrovasc. Brain. Metab. Rev. 2:1990;106-147.
3. Flint Beal M. Mechanism of excitotoxicity in neurologic disease. FASEB J. 6:1992;3338-3344.
4. 2+ and cGMP concentrations of sulphur-containing excitatory amino acids in cultured cerebral cortical neurones. J. Neurosci. Res. 34(3):1993;331-339.
5. Heafield M.T.E., Fearn S., Steventon G.B., Waring R.H., Williams A.C. Plasma cysteine and sulphate levels in motor neuron, Parkinsons and Alzheimers disease. Neurosci. Lett. 110:1990;216-220.
6. Martyn, C.W., 1994. Epidemiology and risk factors for motor neuron disease. In: Williams, A.C. (Ed.), Motor Neuron Disease. Chapman and Hall, London. pp. 393-426.
7. Mitchell, S.C., Waring, R.H., Steventon, G.B., 1992. Variations in the S-oxidation of cysteine derivatives. In: Kalow, W. (Ed.), Pharmacogenetics of Drug Metabolism. Pergammon Press, London, pp. 367-382.
8. Moldeus P., Hogberg J., Orrenius S. Isolation and use of liver cells. Methods Enzymol. 52:1978;60-71.
9. Olney J.W., Zonemski C., Price M.T., Labruyere J. L-Cysteine, a bicarbonate-sensitive endogenous excitotoxin. Science. 248:1990;596-599.
10. Pean A.R., Steventon G.B., Waring R.H., Foster H., Sturman S., Williams A.C. Pathways of cysteine metabolism in MND/ALS. J. Neurol. Sci. 124(Suppl.):1994;59-61.
11. Pean A.R., Parsons R.B., Williams A.C., Waring R.H., Ramsden D.B. Toxicity of sulphur-containing compounds to neuronal cell lines. J. Neurol. Sci. 129(Suppl.):1995;107-108.
12. Porter R.H., Roberts P.J. Glutamate metabotropic receptor activation in neonatal rat cerebral cortex by sulphur-containing excitoatory amino acids. Neurosci. Lett. 154(1-2):1993;28-30.
13. Waring, R.H., 1994. Xenobiotic metabolism in motor neuron disease. In: Williams, A.C. (Ed.), Motor Neuron Disease. Chapman and Hall, London, pp. 465-476.